INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 2.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $403,000 | -16.6% | 2,430 | +21.5% | 0.40% | -2.2% |
| Q2 2015 | $483,000 | -14.4% | 2,000 | 0.0% | 0.41% | -5.5% |
| Q1 2015 | $564,000 | -83.5% | 2,000 | -90.9% | 0.43% | -84.0% |
| Q4 2014 | $3,416,000 | +622.2% | 21,900 | +995.0% | 2.70% | +466.5% |
| Q3 2014 | $473,000 | 0.0% | 2,000 | 0.0% | 0.48% | +6.5% |
| Q2 2014 | $473,000 | -28.3% | 2,000 | 0.0% | 0.45% | -21.0% |
| Q1 2014 | $660,000 | +0.8% | 2,000 | -79.2% | 0.57% | -15.9% |
| Q4 2013 | $655,000 | -1.2% | 9,598 | 0.0% | 0.67% | -6.9% |
| Q3 2013 | $663,000 | +48.0% | 9,598 | -4.0% | 0.72% | +10.4% |
| Q2 2013 | $448,000 | – | 10,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |